The regulatory challenge of counterfeit medicines

被引：0
|
作者：
Lee, M. G. [1 ]
机构：
[1] Med & Healthcare Prod Regulatory Agcy, BP & Lab Serv, London SW8 5NQ, England
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 2007年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
201
引用
收藏
页码：A74 / A74
页数：1
相关论文
共 50 条
  • [41] Analytical tools to fight against counterfeit medicines
    Marini, Roland DjanG'EinG'A
    Kindenge, Jeremie Mbinze
    Montes, Maria de Lourdes Aja
    Debrus, Benjamin
    Lebrun, Pierre
    Mantanus, Jerome
    Ziemons, Eric
    Rohrbasser, Claude
    Rudaz, Serge
    Hubert, Philipe
    CHIMICA OGGI-CHEMISTRY TODAY, 2010, 28 (05) : 10 - 14
  • [42] COUNTERFEIT AND FALSIFIED MEDICINES IN THE EUA LEGAL PERSPECTIVE
    Blakeney, Michael
    UNIVERSITY OF WESTERN AUSTRALIA LAW REVIEW, 2022, 49 (02): : 341 - 344
  • [43] Counterfeit medicines sale on online pharmacies in India
    Nagaraj, Anup
    Tambi, Swasti
    Shravani, G.
    Biswas, Gautam
    Kumawat, Himanshu
    Mathur, Gaurav
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2014, 3 (04) : 145 - 146
  • [44] Counterfeit Medicines in Cambodia-Possible Causes
    Khan, Mohiuddin Hussain
    Okumura, Junko
    Sovannarith, Tey
    Nivanna, Nam
    Nagai, Hiroto
    Taga, Masatoshi
    Yoshida, Naoko
    Akazawa, Manabu
    Tanimoto, Tsuyoshi
    Kimura, Kazuko
    PHARMACEUTICAL RESEARCH, 2011, 28 (03) : 484 - 489
  • [45] Counterfeit Medicines-Japan and the World-
    Sato, Daisaku
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2014, 134 (02): : 213 - 222
  • [46] Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions
    Ellen 't Hoen
    Fernando Pascual
    Journal of Public Health Policy, 2015, 36 : 384 - 389
  • [47] Health professionals in the risk communication process on counterfeit medicines
    Besancon, Luc
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2012, 1 (3-4): : 135 - 137
  • [48] COVID-19 Pandemic: A Surge in Counterfeit Medicines
    Ussai, S.
    DRUG SAFETY, 2022, 45 (10) : 1181 - 1181
  • [49] Gulucatime versus Glucantime: A Serious Warning on Counterfeit Medicines
    Abtahi-Naeini, Bahareh
    Shahmoradi, Zabihollah
    Niknami, Elmira
    Saffaei, Ali
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2019, 8 (04) : 228 - +
  • [50] The use of near infrared spectroscopy to detect counterfeit medicines
    Moffat, Tony
    Watt, Robert
    Assi, Sulaf
    Spectroscopy Europe, 2010, 22 (05): : 6 - 10
12345